NASDAQ:GWPH
Delisted

Gw Pharmaceuticals Stock News

etoro logo Buy GWPH
*Your capital is at risk
$218.96
+0 (+0%)
At Close: May 27, 2022
This was a tough week for cannabis stocks, with all ETFs down driven by disappointing earnings reports. Over the five trading days of the week: The ETFMG Alternative Harvest ETF...
Eleva su cartera de proyectos en el país a más de 5 GW
Regulatory News: Total (Paris:FP) (LSE:TTA) (NYSE:TOT) renforce sa présence sur le marché de l’électricité en Espagne grâce à un accord avec le dévelo
Despite its recent share price increase, Evogene continues to be undervalued given the sum of parts valuation of its 4 main subsidiaries and $45 million cash position.

GW Pharmaceuticals: Buy the Dip? | The Motley Fool

12:00pm, Wednesday, 23'rd Sep 2020
The stock has fallen more than 20% in just the past three months.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Arena Pharmaceuticals, Inc...
Advisor Group Holdings Inc. cut its position in shares of GW Pharmaceuticals PLC- (NASDAQ:GWPH) by 37.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange
Bank of America Corp DE trimmed its holdings in GW Pharmaceuticals PLC- (NASDAQ:GWPH) by 23.9% during the second quarter, Holdings Channel reports. The institutional investor owned 360,760 shares of t
GW Pharmaceuticals plc (NASDAQ:GWPH) Morgan Stanley 18th Annual Global Healthcare Conference September 15, 2020 4:15 PM ET Company Participants Justin Gover - Chief Executive Officer Darren Cline - Ch
Stifel Financial Corp grew its holdings in shares of GW Pharmaceuticals PLC- (NASDAQ:GWPH) by 0.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange
Rolling coverage of the latest economic and financial news, as ECB says the eurozone saw a strong rebound over the summer
Investors will want to preserve their hard-earned capital by staying away from these marijuana companies for now.
Pot stocks aren't really the go-to choice for institutional investors, but with GW Pharmaceuticals PLC (NASDAQ:GWPH), things may be starting to change.
Both have struggled over the past year, but there are reasons to expect their stocks could stage strong comebacks over the longer term.
Everyone agrees that cannabis in the 21st century is far different than cannabis of the past - much of that has to do with terpenes.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE